Pix: Dr Ayman Al-Sulaimani
The implementation of a generic medicine framework in Saudi Arabia can result in an estimated decrease of 35%-40%, equivalent to SAR10bn ($2.7bn), in medication spending annually, says Bupa Arabia for Cooperative Insurance in a new report.
If you are already a subscriber
OR sign-up for a trial access here
Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.